168 related articles for article (PubMed ID: 6987030)
21. Comparison of renal function parameters in the assessment of cis-platin induced nephrotoxicity.
Verplanke AJ; Herber RF; de Wit R; Veenhof CH
Nephron; 1994; 66(3):267-72. PubMed ID: 7910667
[TBL] [Abstract][Full Text] [Related]
22. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.
Diener U; Knoll E; Langer B; Rautenstrauch H; Ratge D; Wisser H
Clin Chim Acta; 1981 May; 112(2):149-57. PubMed ID: 6113066
[TBL] [Abstract][Full Text] [Related]
23. Administration of gallium nitrate by continuous infusion: lack of chronic nephrotoxicity confirmed by studies of enzymuria and beta 2-microglobulinuria.
Leyland-Jones B; Bhalla RB; Farag F; Williams L; Coonley CJ; Warrell RP
Cancer Treat Rep; 1983 Oct; 67(10):941-2. PubMed ID: 6354440
[TBL] [Abstract][Full Text] [Related]
24. Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9).
Skillen AW; Buamah PK; Cantwell BM; Cornell C; Hodson AW; Harris AL
Cancer Chemother Pharmacol; 1988; 22(3):228-34. PubMed ID: 3044631
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
Minakami H
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury.
Pfaller W; Thorwartl U; Nevinny-Stickel M; Krall M; Schober M; Joannidis M; Hobisch A
Kidney Int Suppl; 1994 Nov; 47():S68-75. PubMed ID: 7532742
[TBL] [Abstract][Full Text] [Related]
27. [Importance of urinary enzymes as a marker of post-ischemic proximal tubular involvement in rat].
Catroux P; Dorian C; Harpey C; Cambar J
C R Seances Soc Biol Fil; 1987; 181(3):307-13. PubMed ID: 2888519
[TBL] [Abstract][Full Text] [Related]
28. Aminoglycoside-related nephrotoxicity in the premature newborn.
Rajchgot P; Prober CG; Soldin S; Perlman M; Good F; Harding E; Klein J; MacLeod S
Clin Pharmacol Ther; 1984 Mar; 35(3):394-401. PubMed ID: 6365403
[TBL] [Abstract][Full Text] [Related]
29. [Neonatal hypoxic-ischemic nephropathy and urinary diagnostic indices: the utility of measuring tubular enzymes (NAG and AAP)].
Bertotti A; De Marchi S; Brovedani P; Gaeta G; Peratoner L; Mangiarotti MA
Pediatr Med Chir; 1990; 12(4):347-9. PubMed ID: 1981610
[TBL] [Abstract][Full Text] [Related]
30. Urinary beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase (NAG) as early markers of renal tubular dysfunction in sick neonates.
Chen JY; Lee YL; Liu CB
J Formos Med Assoc; 1991 Feb; 90(2):132-7. PubMed ID: 1678405
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic value of urinary enzyme measurements in hypertension.
Johnston ID; Jones NF; Scoble JE; Yuen CT; Price RG
Clin Chim Acta; 1983 Oct; 133(3):317-25. PubMed ID: 6414744
[TBL] [Abstract][Full Text] [Related]
32. Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment.
Hacke M; Schmoll HJ; Alt JM; Baumann K; Stolte H
Clin Physiol Biochem; 1983; 1(1):17-26. PubMed ID: 6383688
[TBL] [Abstract][Full Text] [Related]
33. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function].
Skrezek C; Bertermann H; Schulz FP; König B
Urologe A; 1990 Jan; 29(1):27-31. PubMed ID: 2316078
[TBL] [Abstract][Full Text] [Related]
34. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
35. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
Crovato E; Salvini R
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
[TBL] [Abstract][Full Text] [Related]
36. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
Saito M; Masaki T; Kato H; Numasaka K
Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
[TBL] [Abstract][Full Text] [Related]
37. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies.
Lebeau C; Debelle FD; Arlt VM; Pozdzik A; De Prez EG; Phillips DH; Deschodt-Lanckman MM; Vanherweghem JL; Nortier JL
Nephrol Dial Transplant; 2005 Nov; 20(11):2321-32. PubMed ID: 16077141
[TBL] [Abstract][Full Text] [Related]
38. [Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma].
Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1990 May; 36(5):535-9. PubMed ID: 1698011
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment.
Skálová S
Acta Medica (Hradec Kralove); 2005; 48(2):75-80. PubMed ID: 16259316
[TBL] [Abstract][Full Text] [Related]
40. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity.
Price RG
Clin Nephrol; 1992; 38 Suppl 1():S14-9. PubMed ID: 1295704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
